Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
5.00
+0.07 (1.42%)
Jan 21, 2025, 4:00 PM EST - Market closed
RGC Market Cap
RGC has a market cap or net worth of $65.06 million as of January 21, 2025. Its market cap has decreased by -69.70% in one year.
Market Cap
65.06M
Enterprise Value
57.19M
1-Year Change
-69.70%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has decreased from $120.10M to $65.06M, a decrease of -45.82%. That is a compound annual growth rate of -16.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 62.72M | -2.43% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |